Johnson & Johnson Proves It’s Healthy with Its 3Q16 Results PART 3 OF 5
Johnson & Johnson (JNJ) registered sales of approximately $6.2 billion in its Medical Devices segment in 2Q16. The Orthopedics and Surgical segments were the major sales contributors, comprising ~36.5% and 37.1%, respectively, of the segments total revenues. However, the Vision Care business reported the highest growth in the quarter of ~8.2%.
Johnson & Johnson (JNJ) focuses on its Medical Devices business restructuring to attain a profitable…
Read the full article at: http://marketrealist.com/2016/10/jnj-moved-to-restructure-its-medical-devices-business-in-3q16/